Activation of A 3 adenosine receptors attenuates lung injury after in vivo reperfusion

Anesthesiology

Volumn 101, Issue 5, 2004, Pages 1153-1159

  Rivo, Julia ^a,b   Zeira, Evelyne ^c   Galun, Eithan ^c   Matot, Idit ^a,b,c  

^a Dept of Anesth/Critical Care Med ^*  (Israel)

^b Laboratory of Experimental Surgery   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; HISTAMINE; MYELOPEROXIDASE; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; N(G) NITROARGININE BENZYL ESTER; N6 (3 IODOBENZYL) N METHYL 5' CARBAMOYLADENOSINE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; ABC TRANSPORTER; ADAMANTANE; ADENOSINE; DIHYDROPYRIDINE DERIVATIVE; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; MORPHOLINE DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; UK ATP 1 POTASSIUM CHANNEL; UK-ATP-1 POTASSIUM CHANNEL;

ANIMAL MODEL; ARTICLE; CAT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; HEART RATE; HEMODYNAMIC PARAMETERS; HISTAMINE BLOOD LEVEL; ISCHEMIA; LUNG INJURY; LUNG TRANSPLANTATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG POTENTIATION; HEMODYNAMICS; IN VITRO STUDY; LUNG; PATHOLOGY; PHYSIOLOGY; PULMONARY ARTERY;

ADAMANTANE; ADENOSINE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CATS; DIHYDROPYRIDINES; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HISTAMINE; LUNG; MORPHOLINES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PULMONARY ARTERY; RECEPTOR, ADENOSINE A3; REPERFUSION INJURY;

EID: 7244244063     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200411000-00015     Document Type: Article

References (48)

1. 3 receptors. Am J Physiol Renal Physiol 2000; 278:F380-7
2. 2a adenosine receptor activation. Am J Kidney Dis 2001; 38:610-8
3. 3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure. Am J Physiol Renal Physiol 2003; 284:F267-73
4. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85:659-65
5. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 1992; 123:332-8
6. 3 receptor-induced delayed cardioprotection in mouse. Am J Physiol Heart Circ Physiol 2003; 285:H434-41
7. Auchampach JA, Rizvi A, Qui Y, Tang XL, Maldonado C, Teschner S, Bolli R: Selective activation of a sub 3 adenosine receptors with N sup 6 (3-iodobenzyl) adenosine-5 prime-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 1997; 80:800-9
8. Liu GS, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey JM: Evidence that the adenosine A sub 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 1994; 28:1057-61
9. Armstrong S, Ganote CE: Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: Evidence of A sub 3 receptor involvement. Cardiovasc Res 1994; 28:1049-56
10. Auchampach JA, Ge ZD, Wan TC, Moore J, Gross GJ: A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 2003; 285:H607-13
11. Marts BC, Baudendistel LJ, Naunheim KS, Dahms TE: Protective effect of 2-chloroadenosine on lung ischemia reperfusion injury. J Surg Res 1993; 54: 523-9
12. Fiser SM, Tribble CG, Kaza AK, Long SM, Kern JA, Cassada DC, Linden J, Rieger J, Laubach VE, Matisoff A, Kron IL: Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. Thorac Cardiovasc Surg 2002; 124:973-8
13. 2 receptors reverse ischemia-reperfusion lung injury independent of β-receptors. J Appl Physiol 1995; 78:990-6
14. 1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol 1995; 268:L1036-46
15. 3 adenosine receptor. Proc Natl Acad Sci U S A 1992; 89:7432-6
16. Salvatore CA, Jacobson MA, Taylor HE, Linden J, Johnson RG: Molecular cloning and characterization of human A sub 3 adenosine receptor. Proc Natl Acad Sci U S A 1992; 90:10365-9
17. Matot I, Jurim O: Protective effect of acadesine on ischemia-reperfusion lung injury. Anesth Analg 2001; 92:590-5
18. Takano H, Bolli R, Black RG, Kodani E, Xiang-Liang T, Zequan Y, Bhattacharya S, Auchampach JA: A1 or A3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 2001; 88:520-8
19. Kodani E, Shinmura K, Xuan UT, Takano H, Auchampach JA, Tang XL, Bolli R: Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors. Am J Physiol Heart Circ Physiol 2001; 281:H959-68
20. 2 receptors mediate tone dependent responses in feline pulmonary vascular bed. Am J Physiol Heart Circ Physiol 1996; 270:H200-7
21. Murata T, Nakazawa H, Mori I, Ohta Y, Yamabayashi H: Reperfusion after two-hour period of pulmonary artery occlusion causes pulmonary necrosis. Am Rev Respir Dis 1992; 146:1048-53
22. Smith EF, Egan JW, Bugelski PJ, Hillegass LM, Hill DE, Griswold DE: Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am J Physiol 1988; 255:H1060-8
23. Suzuki K, Murtuza B, Smolenski RT, Sammut I, Suzuki N, Kneda Y, Yacoub MH: Overexpression of interleukin-1 antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001; 104:1308-13
24. Fadel E, Mazmanian GM, Chapelier B, Baudet B, Detruit H, de Montpreville V, Libert JM, Wartske M, Herve P, Darrevelle P: Lung reperfusion injury after chronic or acute unilateral pulmonary artery occlusion. Am J Respir Crit Care Med 1998; 157:1294-300
25. Walker BA, Jacobson MA, Knight DA, Salvatore CA, Weir T, Zhou D, Bai TR: Adenosine A3 receptor expression and function in eosinophils, Am J Respir Cell Mol Biol 1997; 16:531-7
26. Von Lubitz DK, Lin RC, Popik P, Carter MF, Jacobson KA: Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 1994; 263:59-67
27. Jacobson KA: Adenosine A3 receptors: Novel ligands and paradoxical effects. Trends Pharmacol Sci 1998; 19:184-91
28. Von Lubitz DK, Simpson KL, Lin RC: Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci 2001; 939:85-96
29. Al-Mehdi AB, Fisher AB: Invited editorial on "Tumor necrosis factor-α in ischemia and reperfusion injury in rat lungs." J Appl Physiol 1998; 85:2003-4
30. Bowlin TL, Borcherding DR, Edwards CK III, McWhinney CD: Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. Cell Mol Biol 1997; 43:345-9
31. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS: Inhibition of TNF-alpha expression by adenosine: Role of A3 adenosine receptors. J Immunol 1996; 156:3435-42
32. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol Heart Circ Physiol 1999; 277:H1895-905
33. Bouma MG, Jeunhomme TM, Boyle DL, Dentener MA, Voitenok NN, van den Wildenberg FA, Buurman WA: Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. J Immunol 1997; 158:5400-8
34. Fischer S, Cassivi SD, Xavier A, Cardella JA, Cutz E, Edwards V, Liu M, Keshavjee S: Cell death in human lung transplantation: Apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 2000; 231: 424-31
35. Fischer S, MacLean AA, Liu M, Cardella JA, Slutsky AS, Suga M, Moreira JFM, Keshavjee S: Dynamic changes and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 2000; 162:1932-9
36. Khono Y, Sie Y, Koshiba M, Kim HO, Jacobson KA: Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A (3) receptor agonists. Biochem Biophys Res Commun 1996; 219:904-10
37. Shneyvays V, Jacobson KA, Li AH, Nawrath H, Zinman T, Isaac A, Shainberg A: Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Exp Cell Res 2000; 257:111-26
38. Yao U, Sei U, Abbrachio MP, Kim UC, Jacobson KA: Adenosine A3 receptor agonist protect HL-70 and U-937 cells from apoptosis induced by A3 antagonists. Biochem Biophys Res Commun 1997; 232:317-22
39. Gallo-Rodriguez C, Ji XD, Melman N, Siegman BD, Sanders LH, Orlina J, Fischer B, Pu Q, Olah ME, van Galen PJ: Structure-activity relationship of N6-benzyladenosine-5 prime-uronamides as A3-selective adenosine agonists. J Med Chem 1994; 37:636-46
40. Hill RJ, Oleynek JJ, Hoth CF, Kiron MA, Weng W, Webster RT, Tracey WR, Knight DR, Buchholz RA, Kennedy SP: Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. J Pharmacol Exp Ther 1997; 280:122-8
41. Linden J: Molecular approach to adenosine receptors: Receptor-mediated mechanisms, of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41:775-87
42. Jacobson KA: Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 1998; 19:184-91
43. 2 analogue, on reperfusion injury to rabbit lungs. Am J Respir Crit Care Med 1998; 158:1669-75
44. Zamora CA, Baron DA, Heffner JE: Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol 1993; 74:224-9
45. 3 receptors: Pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 1994; 15:298-306
46. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: Studies in knock-out mice. Biochim Biophys Acta 2000; 1500:280-90
47. Thiele A, Kronstein R, Wetzel A, Gerth A, Nieber K, Hauschildt S: Regulation of adenosine receptor subtypes during cultivation of human monocytes: role of receptors in preventing lipopolysaccharide-triggered respiratory burst. Infect Immum 2004; 72:1349-57
48. Bouma MG, Jeunhomme TM, Boyle DL, Dentener MA, Voitenok NN, van den Wildenberg FA, Buurman WA: Adenosine inhibits neutrophil degranulation in activated human whole blood: Involvement of adenosine A2 and A3 receptors. J Immunol 1997; 158:5400-8